TY - JOUR
T1 - MTOR regulates metabolic adaptation of APCs in the lung and controls the outcome of allergic inflammation
AU - Sinclair, Charles
AU - Bommakanti, Gayathri
AU - Gardinassi, Luiz
AU - Loebbermann, Jens
AU - Johnson, Matthew Joseph
AU - Hakimpour, Paul
AU - Hagan, Thomas
AU - Benitez, Lydia
AU - Todor, Andrei
AU - Machiah, Deepa
AU - Oriss, Timothy
AU - Ray, Anuradha
AU - Bosinger, Steven
AU - Ravindran, Rajesh
AU - Li, Shuzhao
AU - Pulendran, Bali
N1 - Publisher Copyright:
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.
PY - 2017/9/8
Y1 - 2017/9/8
N2 - Antigen-presenting cells (APCs) occupy diverse anatomical tissues, but their tissuerestricted homeostasis remains poorly understood. Here, working with mouse models of inflammation, we found that mechanistic target of rapamycin (mTOR)-dependent metabolic adaptation was required at discrete locations. mTOR was dispensable for dendritic cell (DC) homeostasis in secondary lymphoid tissues but necessary to regulate cellular metabolism and accumulation of CD103+ DCs and alveolar macrophages in lung. Moreover, while numbers of mTOR-deficient lung CD11b+ DCs were not changed, they were metabolically reprogrammed to skew allergic inflammation from eosinophilic T helper cell 2 (TH2) to neutrophilic TH17 polarity. The mechanism for this change was independent of translational control but dependent on inflammatory DCs, which produced interleukin-23 and increased fatty acid oxidation. mTOR therefore mediates metabolic adaptation of APCs in distinct tissues, influencing the immunological character of allergic inflammation.
AB - Antigen-presenting cells (APCs) occupy diverse anatomical tissues, but their tissuerestricted homeostasis remains poorly understood. Here, working with mouse models of inflammation, we found that mechanistic target of rapamycin (mTOR)-dependent metabolic adaptation was required at discrete locations. mTOR was dispensable for dendritic cell (DC) homeostasis in secondary lymphoid tissues but necessary to regulate cellular metabolism and accumulation of CD103+ DCs and alveolar macrophages in lung. Moreover, while numbers of mTOR-deficient lung CD11b+ DCs were not changed, they were metabolically reprogrammed to skew allergic inflammation from eosinophilic T helper cell 2 (TH2) to neutrophilic TH17 polarity. The mechanism for this change was independent of translational control but dependent on inflammatory DCs, which produced interleukin-23 and increased fatty acid oxidation. mTOR therefore mediates metabolic adaptation of APCs in distinct tissues, influencing the immunological character of allergic inflammation.
UR - http://www.scopus.com/inward/record.url?scp=85027343436&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85027343436&partnerID=8YFLogxK
U2 - 10.1126/science.aaj2155
DO - 10.1126/science.aaj2155
M3 - Article
C2 - 28798047
AN - SCOPUS:85027343436
SN - 0036-8075
VL - 357
SP - 1014
EP - 1021
JO - Science
JF - Science
IS - 6355
ER -